Montana Code Annotated (2013)
Table of Contents / TITLE 50. HEALTH AND SAFETY / CHAPTER 32. CONTROLLED SUBSTANCES
Part 2. Scheduling of Dangerous Drugs
Current Version 2025, 2023, 2021, 2019, 2017, 2015, 2013, 2011, 2009, 2007, 2005, 2003, 2001, 1999, 1997, 1995
50-32-201 - General criteria to be considered
50-32-202 - Designation of drug as dangerous drug
50-32-203 - Effect of rescheduling under federal law
50-32-204 - Immediate precursors
50-32-205 - Nonprescription drugs not to be scheduled
50-32-206 - Use of names of scheduled drugs
50-32-207 - Order forms for drugs in Schedules I and II
50-32-208 - Prescription and medical requirements for scheduled drugs -- penalty
50-32-209 - Republication of schedules
50-32-221 - Criteria for placement of drug in Schedule I
50-32-222 - Specific dangerous drugs included in Schedule I
50-32-223 - Criteria for placement of drug in Schedule II
50-32-224 - Specific dangerous drugs included in Schedule II
50-32-225 - Criteria for placement of drug in Schedule III
50-32-226 - Specific dangerous drugs included in Schedule III
50-32-227 - Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III
50-32-228 - Criteria for placement of drug in Schedule IV
50-32-229 - Specific dangerous drugs included in Schedule IV
50-32-230 - Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV
50-32-231 - Criteria for placement of drug in Schedule V
50-32-232 - Specific dangerous drugs included in Schedule V
50-32-233 - Exempt anabolic steroid products